Comparison of relative frequency of treatment response and complications incidence in two therapeutic groups of patients with hypoparathyroidism treated with 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol referred to clinics of Ahwaz educational hospitals in the years 2010–2020

ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Ghaderian SB, Sadrian A, Rashidi H, Sedaghat A. Comparison of relative frequency treatment response and complications incidence in two therapeutic groups patients with hypoparathyroidism treated 1,25-dihydroxycholecalciferol 25-hydroxycholecalciferol referred to clinics Ahwaz educational hospitals the years 2010–2020. Family Medicine & Primary Care Review. 2022;24(4):317-321. doi:10.5114/fmpcr.2022.120853. APA Ghaderian, S. B., Sadrian, A., Rashidi, H., Sedaghat, (2022). Review, 24(4), 317-321. https://doi.org/10.5114/fmpcr.2022.120853 Chicago Seyed B, AmirAbas Homeira Alireza Sedaghat. 2022. "Comparison 2010–2020". Review 24 (4): Harvard S., pp.317-321. MLA et al. 2010–2020." vol. 24, no. 4, 2022, pp. Vancouver S,